Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study.

BACKGROUND As part of the prospective multicenter ImageKids study, we aimed to develop and validate the pediatric MRI-based perianal Crohn disease (PEMPAC) index. METHODS Children with Crohn disease with any clinical perianal findings underwent pelvic magnetic resonance imaging at 21 sites globally. The site radiologist and 2 central radiologists provided a radiologist global assessment (RGA) on a 100 mm visual analog scale and scored the items selected by a Delphi group of 35 international radiologists and a review of the literature. Two weighted multivariable statistical models were constructed against the RGA. RESULTS Eighty children underwent 95 pelvic magnetic resonance imaging scans; 64 were used for derivation and 31 for validation. The following items were included: fistula number, location, length and T2 hyperintensity; abscesses; rectal wall involvement; and fistula branching. The last 2 items had negative beta scores and thus were excluded in a contending basic model. In the validation cohort, the full and the basic models had the same strong correlation with the RGA (r = 0.75; P < 0.01) and with the adult Van Assche index (VAI; r = 0.93 and 0.92; P < 0.001). The correlation of the VAI with the RGA was similar (r = 0.77; P < 0.01). The 2 models and the VAI had a similar ability to differentiate remission from active disease (area under the receiver operating characteristic curve, 0.91-0.94). The PEMPAC index had good responsiveness to change (area under the receiver operating characteristic curve, 0.89; 95% confidence interval, 0.69-1.00). CONCLUSIONS Using a blended judgmental and mathematical approach, we developed and validated an index for quantifying the severity of perianal disease in children with CD. The adult VAI may also be used with confidence in children.

[1]  J. Adler,et al.  Factors Associated With Development of Perianal Fistulas in Pediatric Patients With Crohn's Disease. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  S. Park,et al.  Supplementary Anal Imaging by Magnetic Resonance Enterography in Patients with Crohn's Disease Not Suspected of Having Perianal Fistulas. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  J. Kim,et al.  Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts , 2020, Pediatric gastroenterology, hepatology & nutrition.

[4]  L. Stitt,et al.  Development and Validation a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease. , 2019, Gastroenterology.

[5]  W. Reinisch,et al.  Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review , 2018, World journal of gastroenterology.

[6]  I. Ordás,et al.  Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease. , 2018, Gastroenterology.

[7]  A. Griffiths,et al.  P128 Development of the Paediatric Inflammatory Crohn's MRE Index (PICMI)- results from the ImageKids Study , 2018 .

[8]  L. Stitt,et al.  The development of a magnetic resonance imaging index for fistulising Crohn's disease , 2017, Alimentary pharmacology & therapeutics.

[9]  J. Adler,et al.  Perianal Crohn Disease in a Large Multicenter Pediatric Collaborative , 2017, Journal of pediatric gastroenterology and nutrition.

[10]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.

[11]  S. Wong,et al.  Changing epidemiological trends of inflammatory bowel disease in Asia , 2016, Intestinal Research.

[12]  J. Lange,et al.  Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial , 2015, Trials.

[13]  C. Alberti,et al.  Predictors of response to infliximab in paediatric perianal Crohn's disease , 2014, Alimentary pharmacology & therapeutics.

[14]  A. Griffiths,et al.  P-046: Damage and inflammatory activity in pediatric Crohn’s disease (CD) based on radiologist and gastroenterologist physician global assessment , 2014 .

[15]  W. Bemelman,et al.  A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease , 2014, Gut.

[16]  S. Ng,et al.  Long‐term MRI‐guided combined anti‐TNF‐&agr; and thiopurine therapy for crohn's perianal fistulas , 2012, Inflammatory bowel diseases.

[17]  A. Griffiths,et al.  Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions , 2012, Inflammatory bowel diseases.

[18]  D. Hommes,et al.  Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease. , 2011, Clinical imaging.

[19]  David C Wilson,et al.  Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.

[20]  E. Louis,et al.  Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. , 2010, Gastroenterology.

[21]  D. Schwartz,et al.  Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohn's disease , 2010, Inflammatory bowel diseases.

[22]  S. Ng,et al.  Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn's Perineal Fistulas , 2009, The American Journal of Gastroenterology.

[23]  R. Meuli,et al.  Diagnostic performance of MRI for detection of intestinal fistulas in patients with complicated inflammatory bowel conditions , 2007, European Radiology.

[24]  P. Rutgeerts,et al.  Infliximab maintenance therapy for fistulizing Crohn's disease. , 2004, The New England journal of medicine.

[25]  G. Marchal,et al.  Magnetic Resonance Imaging of the Effects of Infliximab on Perianal Fistulizing Crohn's Disease , 2003, American Journal of Gastroenterology.

[26]  B. George,et al.  A Randomized, Controlled Trial of Fibrin Glue vs. Conventional Treatment for Anal Fistula , 2002, Diseases of the colon and rectum.

[27]  J. Morris,et al.  MR imaging classification of perianal fistulas and its implications for patient management. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[28]  P. Rutgeerts,et al.  Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.

[29]  D. Wilson,et al.  Outcome after surgery for perianal fistula: predictive value of MR imaging. , 1998, AJR. American journal of roentgenology.

[30]  P. gordon,et al.  A classification of fistula‐in‐ano , 1976 .

[31]  K. Zimmer,et al.  Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA-GPGE Registry , 2018, Journal of pediatric gastroenterology and nutrition.

[32]  M. Gee,et al.  MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults , 2013, Pediatric Radiology.

[33]  A. Griffiths,et al.  Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  E. Irvine Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. , 1995, Journal of clinical gastroenterology.

[35]  R A Deyo,et al.  Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. , 1986, Journal of chronic diseases.